• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将抗疟药物咯萘啶重新用作DNA修复抑制剂,以充分发挥金纳米颗粒介导的辐射反应的潜力。

Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response.

作者信息

Jackson Nolan, Alhussan Abdulaziz, Bromma Kyle, Jay David, Donnelly James C, West Frederick G, Lavasanifar Afsaneh, Weinfeld Michael, Beckham Wayne, Chithrani Devika B

机构信息

Department of Physics and Astronomy, University of Victoria, Victoria, BC V8P 5C2, Canada.

Department of Oncology, Division of Experimental Oncology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1Z2, Canada.

出版信息

Pharmaceutics. 2022 Dec 14;14(12):2795. doi: 10.3390/pharmaceutics14122795.

DOI:10.3390/pharmaceutics14122795
PMID:36559288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9783290/
Abstract

Radiation therapy (RT) is frequently used to locally treat tumors. One of the major issues in RT is normal tissue toxicity; thus, it is necessary to limit dose escalation for enhanced local control in patients that have locally advanced tumors. Integrating radiosensitizing agents such as gold nanoparticles (GNPs) into RT has been shown to greatly increase the cure rate of solid tumors. The objective of this study was to explore the repurposing of an antimalarial drug, pyronaridine (PYD), as a DNA repair inhibitor to further enhance RT/GNP-induced DNA damage in cancerous cell lines. We were able to achieve inhibitory effects of DNA repair due to PYD at 500 nM concentration. Our results show a significant enhancement in DNA double-strand breaks of 42% in HeLa cells treated with PYD/GNP/RT in comparison to GNP/RT alone when irradiated with a dose of 2 Gy. Furthermore, there was a significant reduction in cellular proliferation for both HeLa and HCT-116 irradiated cells with the combined treatment of PYD/GNP/RT. Therefore, the emergence of promising novel concepts introduced in this study could lay the foundation for the transition of this treatment modality into clinical environments.

摘要

放射治疗(RT)常用于局部治疗肿瘤。放射治疗的主要问题之一是正常组织毒性;因此,对于局部晚期肿瘤患者,有必要限制剂量递增以加强局部控制。将诸如金纳米颗粒(GNP)等放射增敏剂整合到放射治疗中已被证明可大大提高实体瘤的治愈率。本研究的目的是探索将抗疟药物咯萘啶(PYD)重新用作DNA修复抑制剂,以进一步增强放射治疗/金纳米颗粒诱导的癌细胞系中的DNA损伤。我们能够在500 nM浓度下实现咯萘啶对DNA修复的抑制作用。我们的结果表明,当用2 Gy剂量照射时,与单独的金纳米颗粒/放射治疗相比,用咯萘啶/金纳米颗粒/放射治疗处理的HeLa细胞中DNA双链断裂显著增强了42%。此外,联合使用咯萘啶/金纳米颗粒/放射治疗时,HeLa和HCT-116照射细胞的细胞增殖均显著降低。因此,本研究中引入的有前景的新概念的出现可为这种治疗方式向临床环境的转变奠定基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/d457c461998a/pharmaceutics-14-02795-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/6fedf2dde92f/pharmaceutics-14-02795-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/cf24f28cd51c/pharmaceutics-14-02795-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/19348d06a08e/pharmaceutics-14-02795-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/829d994c6229/pharmaceutics-14-02795-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/b0161c6c6dd2/pharmaceutics-14-02795-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/45b8c3579cd6/pharmaceutics-14-02795-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/5414a069822e/pharmaceutics-14-02795-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/d457c461998a/pharmaceutics-14-02795-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/6fedf2dde92f/pharmaceutics-14-02795-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/cf24f28cd51c/pharmaceutics-14-02795-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/19348d06a08e/pharmaceutics-14-02795-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/829d994c6229/pharmaceutics-14-02795-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/b0161c6c6dd2/pharmaceutics-14-02795-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/45b8c3579cd6/pharmaceutics-14-02795-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/5414a069822e/pharmaceutics-14-02795-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/9783290/d457c461998a/pharmaceutics-14-02795-g008.jpg

相似文献

1
Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response.将抗疟药物咯萘啶重新用作DNA修复抑制剂,以充分发挥金纳米颗粒介导的辐射反应的潜力。
Pharmaceutics. 2022 Dec 14;14(12):2795. doi: 10.3390/pharmaceutics14122795.
2
Incorporation of Low Concentrations of Gold Nanoparticles: Complex Effects on Radiation Response and Fate of Cancer Cells.低浓度金纳米颗粒的掺入:对癌细胞辐射反应和命运的复杂影响。
Pharmaceutics. 2022 Jan 11;14(1):166. doi: 10.3390/pharmaceutics14010166.
3
Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin.纳米技术驱动的癌症放化疗:通过金纳米颗粒与博来霉素的独特组合充分发挥放射治疗的潜力
Pharmaceutics. 2022 Jan 20;14(2):233. doi: 10.3390/pharmaceutics14020233.
4
Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics.通过纳米颗粒和化疗药物双重增强前列腺癌的放射敏感性
Cancer Nanotechnol. 2023;14(1):75. doi: 10.1186/s12645-023-00228-0. Epub 2023 Sep 29.
5
Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy.将金纳米颗粒与其他放射增敏剂相结合以释放癌症放射治疗的全部潜力。
Pharmaceutics. 2021 Mar 25;13(4):442. doi: 10.3390/pharmaceutics13040442.
6
Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy.用多西他赛调节纳米颗粒摄取、细胞内分布和滞留以增强放射治疗。
Br J Radiol. 2020 Feb 1;93(1106):20190742. doi: 10.1259/bjr.20190742. Epub 2019 Dec 12.
7
Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons.金纳米颗粒在放射治疗中引起的血管损伤:质子、兆伏光子和千伏光子的比较。
Med Phys. 2015 Oct;42(10):5890-902. doi: 10.1118/1.4929975.
8
Modeling gold nanoparticle radiosensitization using a clustering algorithm to quantitate DNA double-strand breaks with mixed-physics Monte Carlo simulation.采用聚类算法结合混合物理蒙特卡罗模拟对金纳米颗粒放射增敏作用进行建模以定量分析 DNA 双链断裂
Med Phys. 2019 Nov;46(11):5314-5325. doi: 10.1002/mp.13813. Epub 2019 Sep 24.
9
Gold nanoparticle mediated radiation response among key cell components of the tumour microenvironment for the advancement of cancer nanotechnology.金纳米颗粒介导的肿瘤微环境关键细胞成分的辐射反应在癌症纳米技术的发展中的作用。
Sci Rep. 2020 Jul 21;10(1):12096. doi: 10.1038/s41598-020-68994-0.
10
Optimal method of gold nanoparticle administration in melanoma-bearing mice.在荷黑素瘤小鼠中给予金纳米颗粒的最佳方法。
Exp Ther Med. 2018 Mar;15(3):2994-2999. doi: 10.3892/etm.2018.5746. Epub 2018 Jan 12.

引用本文的文献

1
Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics.一种新型ERCC1-XPF抑制剂的纳米递送用于结直肠癌对铂类化疗药物的靶向增敏
Drug Deliv Transl Res. 2025 Jan 29. doi: 10.1007/s13346-024-01782-9.
2
Inter-Species Pharmacokinetic Modeling and Scaling for Drug Repurposing of Pyronaridine and Artesunate.种间药代动力学模型构建与标度用于吡喹酮和青蒿琥酯的药物再利用。
Int J Mol Sci. 2024 Jun 26;25(13):6998. doi: 10.3390/ijms25136998.

本文引用的文献

1
Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel.在多西他赛存在的情况下,增强二维、三维和异种移植小鼠癌细胞模型中的纳米颗粒积累。
Sci Rep. 2022 Aug 5;12(1):13508. doi: 10.1038/s41598-022-17752-5.
2
Potential of Gold Nanoparticle in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblast Cells.使用癌细胞与癌症相关成纤维细胞共培养模型研究金纳米颗粒在当前放射治疗中的潜力。
Cancers (Basel). 2022 Jul 22;14(15):3586. doi: 10.3390/cancers14153586.
3
Prostate Apoptosis Response-4 (Par-4): A Novel Target in Pyronaridine-Induced Apoptosis in Glioblastoma (GBM) Cells.
前列腺凋亡反应蛋白4(Par-4):磷酸咯萘啶诱导胶质母细胞瘤(GBM)细胞凋亡的新靶点。
Cancers (Basel). 2022 Jun 29;14(13):3198. doi: 10.3390/cancers14133198.
4
Modulation of ERCC1-XPF Heterodimerization Inhibition Structural Modification of Small Molecule Inhibitor Side-Chains.ERCC1-XPF异二聚化抑制的调节:小分子抑制剂侧链的结构修饰
Front Oncol. 2022 Mar 17;12:819172. doi: 10.3389/fonc.2022.819172. eCollection 2022.
5
Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin.纳米技术驱动的癌症放化疗:通过金纳米颗粒与博来霉素的独特组合充分发挥放射治疗的潜力
Pharmaceutics. 2022 Jan 20;14(2):233. doi: 10.3390/pharmaceutics14020233.
6
The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression .抗疟药物咯萘啶抑制乳腺癌细胞中的拓扑异构酶II并阻碍肿瘤进展。
Clin Cancer Drugs. 2021 Mar;8(1):50-56. doi: 10.2174/2212697x08666210219101023. Epub 2021 Feb 19.
7
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
8
Breast radiotherapy with kilovoltage photons and gold nanoparticles as radiosensitizer: An in vitro study.千伏级光子联合金纳米颗粒作为放射增敏剂的乳腺癌放射治疗:一项体外研究。
Med Phys. 2022 Jan;49(1):568-578. doi: 10.1002/mp.15348. Epub 2021 Dec 1.
9
Radiosensitization Effect of Gold Nanoparticles in Proton Therapy.金纳米颗粒在质子治疗中的放射增敏作用。
Front Public Health. 2021 Jul 29;9:699822. doi: 10.3389/fpubh.2021.699822. eCollection 2021.
10
Pyronaridine induces apoptosis in non-small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor.胡椒乙胺诱导非小细胞肺癌细胞凋亡通过上调死亡受体 5 的表达和抑制表皮生长因子受体。
Chem Biol Drug Des. 2022 Jan;99(1):83-91. doi: 10.1111/cbdd.13926. Epub 2021 Aug 1.